RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Imamura, Mitsuru | - |
dc.contributor.author | Moon, Jong-Seok | - |
dc.contributor.author | Chung, Kuei-Pin | - |
dc.contributor.author | Nakahira, Kiichi | - |
dc.contributor.author | Muthukumar, Thangamani | - |
dc.contributor.author | Shingarev, Roman | - |
dc.contributor.author | Ryter, Stefan W. | - |
dc.contributor.author | Choi, Augustine M. K. | - |
dc.contributor.author | Choi, Mary E. | - |
dc.date.accessioned | 2021-08-11T12:43:42Z | - |
dc.date.available | 2021-08-11T12:43:42Z | - |
dc.date.issued | 2018-02-08 | - |
dc.identifier.issn | 2324-7703 | - |
dc.identifier.issn | 2379-3708 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6214 | - |
dc.description.abstract | Renal fibrosis is a common pathogenic response to injury in chronic kidney disease (CKD). The receptor-interacting protein kinase-3 (RIPK3), a regulator of necroptosis, has been implicated in disease pathogenesis. In mice subjected to unilateral ureteral obstruction-induced (UUO-induced) or adenine diet-induced (AD-induced) renal fibrosis, models of progressive kidney fibrosis, we demonstrate increased kidney expression of RIPK3. Mice genetically deficient in RIPK3 displayed decreased kidney fibrosis and improved kidney function relative to WT mice when challenged with UUO or AD. In contrast, mice genetically deficient in mixed-lineage kinase domain-like protein (MLKL), a downstream RIPK3 target, were not protected from UUO-induced kidney fibrosis. We demonstrate a pathway by which RIPK3 promotes fibrogenesis through the AKT-dependent activation of ATP citrate lyase (ACL). Genetic or chemical inhibition of RIPK3 suppressed the phosphorylation of AKT and ACL in response to TGF-beta 1 in fibroblasts. Inhibition of AKT or ACL suppressed TGF-beta 1-dependent extracellular matrix production and myofibroblast differentiation in fibroblasts. Pharmacological inhibition of ACL suppressed UUO-induced kidney fibrosis. RIPK3 expression was highly regulated in human CKD kidney. In conclusion, we identify a pathway by which RIPK3 promotes kidney fibrosis independently of MLKL-dependent necroptosis as a promising therapeutic target in CKD. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | The American Society for Clinical Investigation | - |
dc.title | RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1172/jci.insight.94979 | - |
dc.identifier.scopusid | 2-s2.0-85052630538 | - |
dc.identifier.wosid | 000425263900004 | - |
dc.identifier.bibliographicCitation | JCI insight, v.3, no.3 | - |
dc.citation.title | JCI insight | - |
dc.citation.volume | 3 | - |
dc.citation.number | 3 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | NLRP3 INFLAMMASOME ACTIVATION | - |
dc.subject.keywordPlus | CELL-DEATH | - |
dc.subject.keywordPlus | PROGRAMMED NECROSIS | - |
dc.subject.keywordPlus | THERAPEUTIC TARGET | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | NECROPTOSIS | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | BETA | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordAuthor | RIPK3 | - |
dc.subject.keywordAuthor | Kidney fibrosis | - |
dc.subject.keywordAuthor | AKT-dependent ATP citrate lyase | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.